Ultrahuman said it has entered a partnership with Click Therapeutics to develop a migraine-focused software feature for its wearable platform, as the company expands its health offerings beyond general wellness tracking.
The feature, called Migraine PowerPlug, will be integrated into the Ultrahuman app and is built on technology from Click Therapeutics’ FDA-authorised prescription digital therapeutic. The companies said the tool is designed to combine biometric data from wearables with evidence-based digital interventions to help users better understand migraine patterns and possible triggers.
See also: Smalth Launches Slim Ceramic Smart Ring With Health Tracking Features
Migraines affect more than one billion people worldwide and disproportionately impact women, the companies said, with women experiencing the condition at nearly three times the rate of men. Migraine is also described as one of the leading causes of disability among women aged 15 to 49.
The Migraine PowerPlug will analyse trends across sleep, stress, recovery, heart rate variability and physical activity, translating those insights into personalised lifestyle guidance such as movement goals, sleep targets and hydration recommendations. The approach is intended to support daily migraine management alongside existing medical care.
See also: RingConn Launches Third-generation Smart Ring With Expanded Feature Set
Ultrahuman said the feature is expected to launch in early 2026 following a pilot phase, with planned availability in markets including the United States, Canada, Europe, India and Australia.
Source: Click Therapeutics